Messenger ribonucleic acid (mRNA)-based therapeutics and the potential of mRNA as a treatment for various conditions has been ...

The observed changes were favorable, but results may have been affected by better-than-normal care in the control arm.

Total and LDL cholesterol variability over time may be a biomarker for higher dementia risk and cognitive decline.

The German Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to assess the benefit of universal blood lipid screening for the early ...

Salk scientists have tracked the flow of trans fats using mouse models to describe the molecular mechanisms that cause trans fats to promote atherosclerotic cardiovascular disease (ASCVD), explaining ...

During the Phase III BROOKLYN trial, patients were randomly assigned in a 2:1 ratio to receive either obicetrapib 10mg or a ...

With it, she says, they “identified approximately 200 lipid features in single cells, with the ability to isolate 96 cells in just a few minutes.” They compared this method to capillary ...

Don't screen everyone, but rather the right ones For the early detection of familial hypercholesterolaemia, IQWiG recommends discussing cascade screening based on affected relatives. English translati ...

Zerlasiran was found to be well tolerated and no significant safety concerns were observed. Credit: Good dreams - Studio via ...

A study in the Journal of the American Chemical Society reports steps toward making inhalable mRNA medicines a possibility.

A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...